Results 1 to 10 of about 2,314,582 (300)

Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment

open access: yesScientific Reports, 2017
Transforming growth factor (TGF)-β1 contributes to autocrine and paracrine functions in the tumor microenvironment (TME). The present study examined the effects of TGF-β1 crosstalk in TME and its role in mediating tumor formation and progression by ...
Lakisha D. Moore-Smith   +4 more
doaj   +2 more sources

The study of FGFR3 ⁃ TACC3 fusion gene mediating pyruvate kinase M2 nuclear translocation to promote DNA damage repair in glioblastoma

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2023
Objective To explore the mechanism of FGFR3⁃TACC3 (F3⁃T3) fusion gene mediating DNA damage repair through promoting pyruvate kinase M2 (PKM2)'s nuclear translocation in glioblastoma.
REN Xiu⁃de   +5 more
doaj   +1 more source

Cytotoxicity of WT1-reactive T cells against Wilms tumor: An implication for antigen-specific adoptive immunotherapy [PDF]

open access: yesBioImpacts, 2023
Introduction: T cells that recognize WT1 peptides have been shown to efficiently eliminate WT1-expressing tumor cells. This study was designed to investigate the feasibility of isolating WT1-reactive T cells from peripheral blood mononuclear cells (PBMCs)
Seyed Mostafa Monzavi   +7 more
doaj   +1 more source

Design and Validation of Experimental Setup for Cell Spheroid Radiofrequency-Induced Heating

open access: yesSensors, 2023
While hyperthermia has been shown to induce a variety of cytotoxic and sensitizing effects on cancer tissues, the thermal dose–effect relationship is still not well quantified, and it is still unclear how it can be optimally combined with other treatment
Ioannis Androulakis   +7 more
doaj   +1 more source

Culturing Mouse Tumor Cells [PDF]

open access: yesCold Spring Harbor Protocols, 2015
Genetically engineered mouse models (GEMMs) are attractive for the study of cancer; however, they can be time-consuming and expensive to produce and maintain. Thus, in certain contexts, the use of in vitro culture systems of tumor cells may provide an efficient and effective means to test hypotheses before assessment in or to complement discoveries in ...
Rhim, Andrew D.   +2 more
openaire   +3 more sources

Why do tumor-infiltrating lymphocytes have variable efficacy in the treatment of solid tumors?

open access: yesFrontiers in Immunology, 2022
Lymphocytes in tumor tissue are called tumor-infiltrating lymphocytes (TILs), and they play a key role in the control and treatment of tumor diseases.
Biaoru Li
doaj   +1 more source

Autocrine Factors Produced by Mesenchymal Stem Cells in Response to CellCell Contact Inhibition Have Anti-Tumor Properties

open access: yesCells, 2023
Recently, mesenchymal stem cell (MSC) therapies have been questioned as MSCs are capable of both promoting and inhibiting tumorigenesis. Both MSCs and tumor cells replicate to increase their population size; however, MSCs, but not tumor cells, stop ...
Jerry P. Chen   +3 more
doaj   +1 more source

Assessing Various Control Samples for Microarray Gene Expression Profiling of Laryngeal Squamous Cell Carcinoma

open access: yesBiomolecules, 2021
Selection of optimal control samples is crucial in expression profiling tumor samples. To address this issue, we performed microarray expression profiling of control samples routinely used in head and neck squamous cell carcinoma studies: human bronchial
Adam Ustaszewski   +7 more
doaj   +1 more source

Experimental model of micronodular thymic neoplasm with lymphoid stroma

open access: yesThoracic Cancer, 2023
Background Micronodular thymic neoplasm with lymphoid stroma (MNT), a subtype of thymic tumor, is histopathologically characterized by micronodular thymic epithelial cell nests with lymphoid stroma.
Riko Niwa   +4 more
doaj   +1 more source

Anti-tumor effects of anti-programmed cell death-1 antibody treatment are attenuated in streptozotocin-induced diabetic mice

open access: yesScientific Reports, 2023
Hyperglycemia impairs immune response; however, it remains unknown whether the anti-tumor effects of anti-programmed cell death-1 antibody (PD-1-Ab) treatment are changed in hyperglycemic conditions.
Masaaki Ito   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy